Search results
Results from the WOW.Com Content Network
Cipla sells active pharmaceutical ingredients to other manufacturers as well as pharmaceutical and personal care products, [20] including the anti-depressant escitalopram oxalate, lamivudine, and fluticasone propionate. [21] Cipla is the world's largest manufacturer of antiretroviral drugs. [20] [22]
Relevant products, such as ARVs and ACTs were also WHO-prequalified. In the same year, the company became the first in Africa to supply Global Fund with ACTs. In 2014, Cipla acquired control of the company, and the company changed its name to Cipla Quality Chemical Industries Limited (CiplaQCIL). In 2016, the company was converted to a public ...
Largest selling pharmaceutical products of 2015. Drugs with sales above $5 billion in 2015 included: [3] [4] Rank Drug Trade name Type Main indications Company
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
On July 29, Cipla an Indian pharmaceutical company bought three products from Teva. [78] Indian pharmaceutical company, Aurobindo, was in the race to buy some Teva assets. In October 2016, Teva has sold off part of its UK and Ireland generic business to Indian pharmaceutical company Intas Pharma for 600 million pounds (5083 crore Indian rupees ...
Exports of pharmaceuticals products from India increased from US$6.23 billion in 2006–07 to US$8.7 billion in 2008-09 a combined annual growth rate of 21.25%. [62] India exported $11.7 billion worth of pharmaceuticals in 2014.
In 2003, discussions began between QCL and the Indian pharmaceutical company Cipla, with the blessing of the Government of Uganda, to establish a joint-venture company in Uganda that would manufacture triple therapy anti retroviral drugs and double therapy antimalarial medication for use in Uganda and nearby countries.
In July 2021, Rubicon Research announced the acquisition of Meditab Specialities Limited’s oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. [14] [15] [16] Meditab Specialities Limited is a wholly owned subsidiary of Cipla Limited. The Satara manufacturing facility is a state-of-the-art cGMP compliant ...